NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next ...
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...
The King met chemotherapy patients and had a go on a robot that is used in surgery during a visit to a hospital. Charles, who is still receiving treatment for an undisclosed form of cancer, was shown ...
The Israeli leader had surgery in 2024 for an enlarged prostate. More recently, follow-up care detected a tumor, his office disclosed on Friday. By David M. Halbfinger Reporting from Jerusalem Prime ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Background/Objectives: Prostate cancer testing relies on prostate-specific antigen testing and digital rectal examination, which have limited specificity and face cultural or geographic barriers to ...
DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ -- PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects ...
Sure, planks and crunches can help you strengthen your core. But are there machines for getting stronger abs at the gym? Integrating gym machine abs workouts into your routine helps you strengthen ...
Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...
What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch well beyond its original purpose? That’s exactly the twist happening with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results